Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Peripheral T-cell Lymphoma”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Large-scale testing (Phase 3)UnknownNCT03623087
What this trial is testing

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Who this might be right for
Non-Hodgkin's Lymphoma, RelapsedNon-Hodgkin T-cell LymphomaNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
The University of Hong Kong 68
Testing effectiveness (Phase 2)Study completedNCT00211185
What this trial is testing

ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Eisai Inc. 49
Testing effectiveness (Phase 2)UnknownNCT05976997
What this trial is testing

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
Liling Zhang 36
Testing effectiveness (Phase 2)Looking for participantsNCT06583083
What this trial is testing

Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Sun Yat-sen University 84
Not applicableActive Not RecruitingNCT01787409
What this trial is testing

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell Lymphoma+12 more
Mayo Clinic 565
Testing effectiveness (Phase 2)UnknownNCT04127227
What this trial is testing

Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

Who this might be right for
NK/T Cell Lymphoma Nos
Sun Yat-sen University 34
Early research (Phase 1)Study completedNCT02809573
What this trial is testing

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Who this might be right for
Peripheral T-cell Lymphoma
Chipscreen Biosciences, Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84
Not applicableLooking for participantsNCT03964480
What this trial is testing

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

Who this might be right for
Peripheral T-Cell Lymphoma
Associazione Angela Serra per la ricerca sul cancro 1,000
Testing effectiveness (Phase 2)Study completedNCT00930605
What this trial is testing

The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
King Chulalongkorn Memorial Hospital 16
Large-scale testing (Phase 3)Looking for participantsNCT05931263
What this trial is testing

Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 104
Testing effectiveness (Phase 2)Study completedNCT03246750
What this trial is testing

B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
The Thai Lymphoma Study Group 34
Large-scale testing (Phase 3)Not Yet RecruitingNCT06255795
What this trial is testing

The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma

Who this might be right for
Extranodal Natural Killer T Cell Lymphoma
Ruijin Hospital 142
Testing effectiveness (Phase 2)UnknownNCT00840385
What this trial is testing

Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)

Who this might be right for
T-Cell LymphomasChemotherapy
Fudan University 30
Testing effectiveness (Phase 2)UnknownNCT03154918
What this trial is testing

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sichuan University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05833893
What this trial is testing

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

Who this might be right for
nk/T-cell LymphomaNewly DiagnosedAdvanced Lymphoma
Chinese PLA General Hospital 10
Not applicableUnknownNCT05896813
What this trial is testing

CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Study completedNCT00290433
What this trial is testing

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 55
Large-scale testing (Phase 3)Looking for participantsNCT06947967
What this trial is testing

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Who this might be right for
Lymphoma, T-Cell, Peripheral
Chipscreen Biosciences, Ltd. 224
Testing effectiveness (Phase 2)Looking for participantsNCT06630091
What this trial is testing

A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study

Who this might be right for
Peripheral T Cell Lymphoma
M.D. Anderson Cancer Center 30
Load More Results